ArticleMedicine2025
Recurrent pneumoperitoneum with pneumatosis cystoides intestinalis in tuberculous pleurisy: Case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationalePneumatosis cystoides intestinalis (PCI) is a rare condition for which autopsy studies have reported a prevalence of 0.03% in the general population. Although PCI can be associated with pneumoperitoneum, many cases are benign and do not reflect viscus perforation. Coexistence with tuberculous pleurisy and recurrent pneumoperitoneum is rare and may be underrecognized. PATIENT CONCERNS: In this report, we present the case of a 38-year-old Tibetan male who experienced tuberculous pleurisy accompanied by recurrent pneumoperitoneum with PCI. Despite the presence of free air, he remained minimally symptomatic. Comprehensive imaging failed to reveal evidence of intestinal perforation, ischemia, or necrosis. Consequently, a nonoperative management strategy was successfully employed, leading to the patient's recovery and discharge. DIAGNOSES: The patient denied any clinical symptoms other than mild abdominal distension. Computed tomography demonstrated PCI involving the transverse colon and hepatic flexure with scattered intraperitoneal free air and no evidence of perforation, ischemia, or necrosis.
interventionsNonoperative management comprised close hemodynamic and abdominal monitoring, bowel rest, low-flow oxygen, and scheduled computed tomography reexamination. Standard antituberculosis therapy was continued. OUTCOMES: In our case, recurrent benign pneumoperitoneum improved with conservative care alone, supporting a standardized, threshold-based, individualized nonoperative approach with ongoing surveillance. Clinically stable PCI patients with pneumoperitoneum and no radiologic or clinical signs of perforation, ischemia, or necrosis are best managed nonoperatively; surgery is reserved for high-risk features. LESSONS: Pneumoperitoneum secondary to PCI is often benign, may not require surgical intervention, and can recur. Tuberculous pleurisy may contribute to PCI with pneumoperitoneum via altered thoracoabdominal pressures. Characteristic computed tomographic findings are instrumental in recognizing PCI and distinguishing it from other causes of pneumoperitoneum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.